ELEVEN BIOTHERAPEUTICS INC - COM (EBIO)

CUSIP: 286221106

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
2,393,349
Share change
+312,845
Total reported value
$5,262,000
Price per share
$2.20
Number of holders
26
Value change
+$807,687
Number of buys
19
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q1 2017

As of 31 Mar 2017, ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,393,349 shares. The largest 10 holders included Flagship Pioneering Inc., BlackRock Inc., VANGUARD GROUP INC, GSA CAPITAL PARTNERS LLP, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and EAGLE GLOBAL ADVISORS LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.